Stuart J. Wong, MD | Froedtert & the ...

Dr. Stuart J. Wong, MD

Claim this profile

Medical College of Wisconsin

Studies Squamous Cell Carcinoma
Studies Head and Neck Squamous Cell Carcinoma
13 reported clinical trials
25 drugs studied

Area of expertise

1

Squamous Cell Carcinoma

Stuart J. Wong, MD has run 9 trials for Squamous Cell Carcinoma. Some of their research focus areas include:

Stage IV
p16 positive
Stage II
2

Head And Neck Squamous Cell Carcinoma

Stuart J. Wong, MD has run 4 trials for Head and Neck Squamous Cell Carcinoma. Some of their research focus areas include:

Stage II
Stage I
p16 negative

Affiliated Hospitals

Image of trial facility.

Medical College Of Wisconsin

Image of trial facility.

Froedtert Menomonee Falls Hospital

Clinical Trials Stuart J. Wong, MD is currently running

Image of trial facility.

Pembrolizumab + Radiation vs Chemotherapy + Radiation

for Head and Neck Cancer

This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.

Recruiting

1 award

Phase 2

31 criteria

Image of trial facility.

Pre-Surgery Chemotherapy + Surgery & Radiation

for Sinus Cancer

This randomized phase II trial studies how well chemotherapy before surgery and radiation therapy works compared to surgery and radiation therapy alone in treating patients with nasal and paranasal sinus cancer that can be removed by surgery. Drugs used in chemotherapy, such as docetaxel, cisplatin, and carboplatin work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors. Giving chemotherapy before surgery and radiation therapy may make the tumor smaller and reduce the amount of normal tissue that needs to be removed and treated with radiation.

Recruiting

1 award

Phase 2

More about Stuart J. Wong, MD

Clinical Trial Related

7 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 4 Active Clinical Trials

Treatments Stuart J. Wong, MD has experience with

  • Cisplatin
  • Pembrolizumab
  • Nivolumab
  • Carboplatin
  • Docetaxel
  • Intensity-Modulated Radiation Therapy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Stuart J. Wong, MD specialize in?

Is Stuart J. Wong, MD currently recruiting for clinical trials?

Are there any treatments that Stuart J. Wong, MD has studied deeply?

What is the best way to schedule an appointment with Stuart J. Wong, MD?

What is the office address of Stuart J. Wong, MD?

Is there any support for travel costs?